Naimish Patel, Chief Medical Officer at CRISPR Therapeutics AG (CRSP), sold 3,150 shares at $48.26 ($152K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Open-market sale of $152k CRSP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2025-05-30 | $283K | — | Filing → |